Group 1 - The major shareholder, Ruizhong Life Insurance Co., Ltd., plans to reduce its holdings in Jiangsu Hualan Pharmaceutical New Materials Co., Ltd. by up to 3,789,267 shares, which accounts for 3.00% of the total share capital [1][2] - The reduction will occur within a three-month period from June 4, 2025, to September 3, 2025, with a trading window where no shares will be sold [1][2] - The reduction will be executed through centralized bidding and block trading, with a maximum of 1,263,089 shares (1.00% of total shares) sold via centralized bidding and 2,526,178 shares (2.00% of total shares) via block trading [1][2] Group 2 - Ruizhong Life Insurance Co., Ltd. has committed to not transferring or entrusting others to manage its shares for a period of 24 months following the initial public offering [3] - The company has confirmed that it has not violated any commitments regarding shareholding and has complied with relevant regulations [5]
华兰股份: 关于持股5%以上股东减持计划的预披露公告